Merck Sues Fresenius To Block Integrilin Generic
Subsidiaries of Merck & Co. Inc. and Takeda Pharmaceutical Co. Ltd on Friday sued Fresenius SE & Co. KGaA's U.S. entities for patent infringement in Delaware court, seeking to block their plans...To view the full article, register now.
Already a subscriber? Click here to view full article